Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Rapidly Evolving Treatments

AACR Lung IO Combo Program Image
Watch this CME-certified on-demand Webcast from the CCO AACR satellite symposium, featuring expert faculty H. Jack West, MD; Hossein Borghaei, MS, DO; and Stephen V. Liu, MD, as they present the latest clinical advances in immunotherapy combinations for lung cancers.
H. Jack West, MD
Program Director
Hossein Borghaei, MS, DO
Stephen V. Liu, MD
Released: June 25, 2019 Expiration: No longer available for credit

Related Content

EHR data analysis from ASCO 2021 showed that NGS testing and clinical trial participation were less likely among Black patients with NSCLC than White patients, as reported by Clinical Care Options (CCO)

Released: June 15, 2021

Download these expert-selected slides on slides on treating patients with NTRK-positive tumors with TRK inhibitors, from Clinical Care Options (CCO).

Alexander Drilon, MD Released: June 11, 2021

Download these expert-selected slides on slides on overcoming acquired resistance with TRK inhibitors, from Clinical Care Options (CCO).

Theodore Laetsch, MD Released: June 11, 2021

Download these expert-selected slides on testing for TRK fusions in your patients with cancer, from Clinical Care Options (CCO).

George D. Demetri, MD Released: June 11, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue